Academic Title:
Associate Professor
Primary Appointment:
Radiation Oncology
Administrative Title:
Billing & Compliance Director; Medical Director for the Maryland Proton Treatment Center (MPTC)
Location:
Maryland Proton Treatment Center (MPTC), 850 W. Baltimore Street, Baltimore, Maryland 21201
Phone (Primary):
410-369-5200
Fax:
410-347-0870
Education and Training
Radiation Oncology Residency
Emory University, 2019
Internship
Emory University, 2015
Medical School
University of Maryland School of Medicine, 2014
Undergraduate
Loyola University Maryland, 2010
Biosketch
Dr. Matthew J. Ferris is an Associate Professor in the Department of Radiation Oncology at the University of Maryland. He specializes in the treatment of head and neck cancers, thoracic cancers, and skin cancers. He serves as the Medical Director of Maryland Proton Treatment Center.
Dr. Ferris grew up in Towson, Maryland. He completed his undergraduate studies in 2010 at Loyola University Maryland where he majored in biology, with minors in business and English, and graduated summa cum laude. He was elected a member of the Phi Beta Kappa Society. He graduated cum laude from the University of Maryland Medical School in 2014, and there was elected a member of the Alpha Omega Alpha Honor Medical Society.
In 2015 he completed a medical internship at Emory University in Atlanta, Georgia, and then he continued on at Emory to complete residency training in radiation oncology in 2019. He served as Chief Resident during his final year of training. During residency, in addition to the busy clinical training, he conducted clinical research in several areas including: cardiac-sparing radiation planning techniques such as cardiac-optimized volumetric modulated arc therapy, and intensity modulated proton therapy, implications of radiation dose to the heart, and effects of radiation dose to the central nervous system on patient symptoms in head and neck cancer.
Dr. Ferris’s ongoing research at the University of Maryland is focused on optimizing advanced radiation techniques, including proton therapy, to maximize control of malignancies while sparing side effects and improving long-term patient reported outcomes. His research has resulted in numerous peer-reviewed publications and has yielded oral presentations at national and international conferences. Dr. Ferris also has keen interest in clinical trial development and enrollment.
Overall, Dr. Ferris strives to work closely with the entire treatment team, including surgeon and medical oncology colleagues, to offer cutting-edge and tailored treatment for each patient. He prizes meticulousness and attention to detail throughout each patient’s course of radiation therapy.
In his spare time, he enjoys the outdoors - surfing, golfing, hunting, and spending time with his family including wife, two daughters, and one son.
Research/Clinical Keywords
General Radiation Oncology, External Beam Radiation, Volumetric Modulated Arc Therapy, 3D Conformal Radiation Therapy, Stereotactic Body Radiation Therapy (SBRT), Stereotactic Radiosurgery (SRS), Proton Therapy, High Dose Rate Brachytherapy (skin), Oligometastatic Disease
Highlighted Publications
Zarinshenas R, Campbell P, Sun K, Molitoris JK, Patel AN, Witek ME, Cullen KJ, Mehra R, Hatten KM, Moyer KF, Taylor RJ, Vakharia KT, Wolf JS, Ferris MJ. Disease and toxicity outcomes for a modern cohort of patients with squamous cell carcinoma of cutaneous origin involving the parotid gland: Comparison of volumetric modulated arc therapy and pencil beam scanning proton therapy. Radiother Oncol. 2024 Apr;193:110112. doi: 10.1016/j.radonc.2024.110112. Epub 2024 Feb 1. PMID: 38309587.
B Savla, J Jatczak, JK Molitoris, ME Witek, K Marter, MJ Zakhary, J Xu, GE Snow, EA Guardiani, MJ Ferris. Pencil beam scanning proton therapy as single vocal cord irradiation for early stage glottic cancer. International Journal of Particle Therapy. First available online July 17, 2024. doi.org/10.1016/j.ijpt.2024.100623
MJ Ferris, KS Martin, JM Switchenko, OA Kayode, J Wolf, Q Dang, RH Press, WJ Curran, and KA Higgins. Sparing cardiac substructures with optimized volumetric modulated arc therapy and intensity-modulated proton therapy in thoracic radiation for locally advanced non-small cell lung cancer. Practical Radiation Oncology 2019. E-pub ahead of print, April 2019. doi: https://doi.org/10.1016/j.prro.2019.04.013
MJ Ferris, R Jiang, M Behera, S Ramalingam, WJ Curran, and KA Higgins. Radiation therapy is associated with an increase in incidence of cardiac events for patients with small-cell lung cancer. Int J Radiat Oncol Biol Phys (Red Journal) 2018; 102: 383 – 390. doi: 10.1016/j.ijrobp.2018.05.066
MJ Ferris, J Zhong, JM Switchenko, KA Higgins, RJ Cassidy, MW McDonald, BR Eaton, KR Patel, CE Steuer, HM Baddour Jr, AH Miller, DW Bruner, C Xiao, and JJ Beitler. Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiotherapy. Radiotherapy and Oncology (Green Journal) 2018; 126: 100-106. doi: 10.1016/j.radonc.2017.08.008
Clinical Specialty Details
Cutaneous (Skin) Radiation Oncology, Thoracic Radiation Oncology, Head and Neck Radiation Oncology